Characteristics of Women Undergoing Frozen Embryo Transfer with VR Hypnosis

50 women aged 18–45 undergoing frozen embryo transfer (FET) at a French public reproductive medicine ward between December 2023 and May 2024. The prospective study assessed the feasibility and anxiolytic effect of a virtual reality medical hypnosis device, measuring anxiety levels and pregnancy outcomes. The dataset likely contains patient characteristics, intervention details, and clinical measurements.

Use Cases

• Analyzing the feasibility of VR medical devices in clinical settings based on the 96% feasibility rate mentioned.
• Studying the impact of non-medical anxiolytic tools on patient anxiety based on pre- and post-procedure STAI-Y1 scores.
• Comparing pregnancy outcomes between intervention and control groups based on the HCG test results and cohort comparison.
• Evaluating patient and caregiver satisfaction with novel medical procedures based on Likert scale assessments.

Strengths

• Includes data from a prospective, single-center clinical study with a defined cohort of 50 women.
• Contains specific outcome measures: feasibility (96%), anxiety scores (mean 28.8/80 post-procedure), and pregnancy rate (40%).
• Data collection period is explicitly stated (December 2023 to May 2024).

Limitations

• Row count and column-level documentation are unknown, which may limit suitability assessment.
• The dataset is very small (9.5 KB), indicating limited scope.
• The study is single-center, so data may reflect geographic or institutional bias.

Provenance

Source

Octavia Pingault via figshare.

Collection Method

Prospective clinical study.

Time Range

December 2023 to May 2024.

Freshness

Last updated 2026-05-26 17:32:34; freshness should be verified.

Geography

A French public reproductive medicine ward.